NanoVibronix Inc gross margin has been in long-term decline. The average rate of decline per year is -2.5%.
The historical rank and industry rank for NanoVibronix's Gross Margin % or its related term are showing as below:
NAOV'
s Gross Margin % Range Over the Past 10 Years
Min: 22.21 Med: 53.61 Max: 67.32
Current: 67.32
During the past 13 years, the highestGross Margin % of NanoVibronix was 67.32%. The lowest was 22.21%. And the median was 53.61%.
NAOV's Gross Margin % is ranked better than 73.37% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 53.135
vs NAOV: 67.32
NanoVibronix had a gross margin of 62.62% for the quarter that ended in Dec. 2023 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for NanoVibronix was -2.50% per year.
NanoVibronix Gross Margin % Historical Data
The historical data trend for NanoVibronix's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NanoVibronix's Gross Margin %
For the Medical Devices subindustry, NanoVibronix's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NanoVibronix's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NanoVibronix's Gross Margin % distribution charts can be found below:
* The bar in red indicates where NanoVibronix's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
NanoVibronix had a gross margin of 62.62% for the quarter that ended in Dec. 2023 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
NanoVibronix Gross Margin % Related Terms
Thank you for viewing the detailed overview of NanoVibronix's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NAOV has been successfully added to your 